Results
Aurobindo Pharma Q1 Net Profit Rises 32% YoY
Aurobindo Pharma's Q1 standalone net profit rose 32% YoY to ₹7,372.2 million, with revenue at ₹27,995.1 million.
The Board approved a merger scheme for three wholly-owned step-down subsidiaries to sim
